CJC-1295 helps restore youthful levels of GH, which can reduce the visible effects of aging and improve skin elasticity
Women are more willing to tolerate injections for weight loss Women were more likely than men to say they would tolerate injections for weight loss despite disliking needles, at 11.23% compared to 7.94%
(Marketscreener [42] is based on Reuters.) Regeneron/Hansoh (Jun 2025) Regeneron in-licensed HS-20094 , a Chinese-developed dual GLP-1/GIP agonist now in Phase 3, paying $80M upfront and up to $1.93B in milestones ( [2] )
Semaglutide for weight loss is not covered by insurance since the medication was first developed for the treatment of type 2 Diabetes, but investing in one's health can lead to long-term benefits both physically and financially
It suggests the drug reached the brain and affected disease-relevant pathways, but that timing, magnitude, delivery, or patient selection were insufficient to overcome established neurodegeneration when used as a stand-alone therapy